Obesity: A Disease

Obesity Medicine

Obesity: A Disease is the official Obesity Medicine Association (OMA) FREE podcast exploring the many facets of the disease of obesity. Episodes provide valuable insights into this growing problem and better equip clinicians to understand and engage in treating this disease.

  1. 19 Oct

    Episode 133: Clinical Conversations: Understanding CKM Syndrome in Obesity Care

    In this episode of Obesity: A Disease, presented by the Obesity Medicine Association (OMA) in collaboration with the American Heart Association (AHA), Dr. Chiadi Ndumele joins the discussion to explore Cardiovascular-Kidney-Metabolic (CKM) Syndrome and its implications for obesity care. Learn how the CKM framework and staging system can help clinicians assess cardiovascular risk, identify opportunities for early intervention, and develop individualized treatment strategies. The conversation also examines the impact of weight loss on cardiometabolic outcomes and the role of lifestyle interventions, anti-obesity medications, and bariatric surgery in improving long-term health. Episode Guest: Chiadi Ndumele, MD, PhD, MHS Episode Host: Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP Chapters (00:00:01) - Introduction and Case Presentation(00:01:05) - Guest Introduction: Dr. Ndumele's Background(00:02:29) - What is Cardiovascular Kidney Metabolic (CKM) Syndrome?(00:03:50) - Shifting Drivers of Cardiometabolic Disease(00:04:55) - Underlying Pathophysiology: Inflammation and Insulin Resistance(00:05:48) - How CKM Guidelines Address Interconnected Risk(00:07:21) - CKM Staging System Explained(00:11:14) - Risk Progression, Synergy, and Mortality(00:12:12) - Metrics for Assessing CKM Risk(00:14:11) - Fatty Liver Disease and the Fib-4 Index(00:14:57) - Using the PREVENT Score and Add-On Variables(00:15:57) - Social Deprivation and Health Equity in CKM(00:17:04) - Obesity as a Centerpiece of Cardiometabolic Risk(00:18:11) - How Much Weight Loss Matters for Cardiometabolic Health(00:20:28) - GLP-1 Agents and Weight-Independent Cardiovascular Benefits(00:21:42) - Key Takeaways for Non-Cardiologist Clinicians(00:24:38) - Closing Thoughts and Sign-Off

  2. 18 Sept

    Episode 132: Clinical Conversations: Using EPSDT to Improve Access to Obesity Pharmacotherapy in Youth

    In this episode of Obesity: A Disease, Dr. Suzanne Cuda, Executive Editor of the Obesity Medicine Association’s Obesity Pillars online journal, interviews Dr. Alaina Vidmar and Dr. Valerie O’Hara about their co-authored article, Using EPSDT to Improve Access to Obesity Pharmacotherapy, published in Obesity Pillars. Together they discuss using the federally mandated Medicated provision, Early and Periodic Screening, Diagnostic and Treatment (EPSDT) to access coverage for obesity treatment of youth in Medicaid programs. Episode Guests: Alaina Vidmar, MD Valerie O’Hara, DO, FAAP, FOMA, DABOM Episode Host: Suzanne Cuda, MD, FOMA, FAAP Related Resources: https://www.sciencedirect.com/science/article/pii/S2667368126000422  Chapters (00:00:01) - Introduction and guest introductions(00:02:51) - What is EPSDT?(00:03:38) - Motivation for the review and personal experiences(00:06:58) - Navigating state vs federal Medicaid rules(00:10:17) - Why obesity deserves EPSDT-based treatment(00:13:05) - Fighting bias and stigma through EPSDT(00:13:51) - Finding resources and champions in your state(00:17:44) - Practical steps: denials, appeals, and letters of necessity(00:19:35) - Variability and challenges across insurers(00:22:29) - Transition to adulthood and coverage gaps(00:24:26) - Using comorbidities and creative coverage strategies(00:28:10) - Advocacy: crafting effective appeal letters(00:31:39) - Case study: dose escalation denial example(00:34:32) - Systemic barriers and future data collection(00:37:35) - Comparing EPSDT to Bridge and Balance programs(00:39:36) - Closing thoughts and thanks

  3. 3 Apr

    Episode 126: Industry Insights: Metabolic Resting Rate

    In this Industry Insights episode of Obesity: A Disease, host Dr. Christopher Weber welcomes Dr. Cameron Garber and Dr. Marc Humbert, metabolic testing specialists with Korr Medical Technologies and hosts of the Metabolic Mastery podcast. Dr. Garber and Dr. Humbert join Dr. Christopher Weber for a focused discussion on resting metabolic rate, exploring its role as a vital sign, its application in nutritional planning, and what the future holds for metabolic testing. This episode is sponsored by Korr Medical Technologies. To learn more about Korr’s metabolic test equipment, visit //KORR.com/OMA or visit them at booth #113 at the 2026 Obesity Medicine Conference in San Diego, CA. Episode Guests: Cameron Garber, DPT Marc Humbert, DPT Episode Host: Christopher Weber, MD, FAAP, FACP, CSCS, DABOM, FOMA The opinions expressed in this podcast are those of the individual speakers and do not represent the views or positions of the Obesity Medicine Association (OMA). This content is intended for informational purposes only. Chapters (00:00:01) - Obesity a Disease(00:01:25) - Resting metabolic rate (RMR)(00:06:53) - MRK: Metabolism, Science(00:13:12) - Exercise and Weight Loss(00:20:49) - Resting metabolic rate(00:24:21) - Metabolic rate monitoring(00:29:57) - Cost of care, Medicare, private insurance(00:31:51) - Heart disease and weight loss(00:41:06) - Weight Loss on GLP1s(00:49:43) - The Future of Weight Loss and Management(00:53:59) - Weight Management: Obesity, a Disease

About

Obesity: A Disease is the official Obesity Medicine Association (OMA) FREE podcast exploring the many facets of the disease of obesity. Episodes provide valuable insights into this growing problem and better equip clinicians to understand and engage in treating this disease.

You Might Also Like